health π¦ Candida auris outbreaks show rising resistance
Ongoing Candida auris cases are confirmed across the US healthcare facilities as of Week 29 ending July 25, 2026. Studies reviewed show Clade I and III have over 90% fluconazole resistance rates. Pan-resistant strains pose a serious clinical threat with 30-day mortality rates between 23% and 67%. Biofilm formation makes eradication tough, prompting research into new antifungals like Manogepix. Tiered prevention strategies, including advanced diagnostics and isolation, are crucial for outbreak control. π¦